Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for complications of ischemic stroke
IRCT20160318027097N5Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Metformin with Placebo (2 arms). Primary endpoint: National Institutes of Health Stroke Scale at month 3. Started Dec 2017; status: completed.
02
Drugs
metformin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20160318027097N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160318027097N5.